Abstract
INACTIVATION of tumour-suppressor genes leads to deregulated cell proliferation and is a key factor in human tumorigenesis. Both p53 and retinoblastoma genes are frequently mutated in human cancers1,2, and the simultaneous inactivation of RB andp53 is frequently observed in a variety of naturally occurring human tumours3. Furthermore, three distinct DNA tumour virus groups-papovaviruses, adenoviruses and human papillomaviruses-transform cells by targeting and inactivating certain functions of both the p53 and retinoblastoma proteins1,2. The cellular oncoprotein, Mdm2, binds to and downmodulates p53 function4–6; its human homologue, MDM2, is amplified in certain human tumours, including sarcomas7–9 and gliomas10. Overproduction of Mdm2 is both tumorigenic4 and capable of immortalizing primary rat embryo fibroblasts11. Here we show that MDM2 interacts physically and functionally with pRB and, as with p53, inhibits pRB growth regulatory function. Therefore, both pRB and p53 can be subjected to negative regulation by the product of a single cellular proto-oncogene.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Levine, A. J., Momand, J. & Finlay, C. A. Nature 351, 453–456 (1991).
Weinberg, R. A. Neuron 11, 191–196 (1993).
Williams, B. O. et al. Nature Genet. 7, 480–484 (1994).
Fakharzadeh, S. S., Trusko, S. P. & George, D. L. EMBO J. 10, 1565–1569 (1991).
Momand, J., Zambetti, G. P., Olson, D., George, D. & Levine A. J. Cell 69, 1237–1245 (1992).
Oliner, J. D. et al. Nature 362, 857–860 (1993).
Oliner, J. D., Kinzler, K. W., Meltzer, P. S., George, D. L. & Vogelstein, B. Nature 358, 80–83 (1992).
Leach, F. S. et al. Cancer Res. 53, 2231–2234 (1993).
Cordon-Cardo et al. Cancer Res. 54, 794–799 (1994).
Reifenberger, G., Liu, L., Ichimura, K., Schimidt, E. E. & Collins, V. P. Cancer Res. 53, 2736–2739 (1993).
Finlay, C. Molec. cell. Biol. 13, 301–306 (1993).
Hu, Q. et al. Molec. cell. Biol. 11, 5792–5799 (1991).
Chen, J., Marechal, V. & Levine, A. J. Molec. cell. Biol. 13, 4107–4114 (1993).
Draetta, G., Brizuela, L., Potashkin, J. & Beach, D. Cell 50, 319–325 (1987).
Cleveland, D. W., Fischer, S. G., Kirshner, M. W. & Laemmli, U. K. J. biol. Chem. 252, 1102–1106 (1977).
Kaelin, W. G., Pallas, D. C., DeCaprio, J. A., Kaye, F. J. & Livingston, D. M. Cell 64, 521–532 (1991).
Cahilly-Snyder, L., Yang-Feng, T., Francke, U. & George, D. L. Somatic Cell molec. Genet. 13, 235–244 (1987).
Qin, X.-Q., Chittenden, T., Livingston, D. M. & Kaelin, W. G. Genes Dev. 6, 953–964 (1992).
Hiebert, S. W. Molec. cell. Biol. 13, 3384–3391 (1993).
Qin, X.-Q. et al. Molec. cell. Biol. 15, 742–755 (1995).
Krek, W., Livingston, D. M. & Shirodkar, S. Science 262, 1557–1560 (1993).
Helin, K. et al. Genes Dev. 7, 1850–1861 (1993).
Slansky, J. E., Li, Y., Kaelin, W. G. & Farnham, P. J. Molec. cell. Biol. 13, 1610–1618 (1993).
Hamel, P. A., Gill, R. M., Philips, R. A. & Gallie, B. L. Oncogene 7, 693–701 (1992).
Flemington, E. K., Speck, S. H. & Kaelin, W. G. Proc. natn. Acad. Sci. U.S.A. 90, 6914–6918 (1993).
Hinds, P. W. et al. Cell 70, 993–1006 (1992).
Morgenbesser, S. D., Williams, B. O., Jacks, T. & DePinho, R. A. Nature 371, 72–74 (1994).
Wu, X. & Levine, A. J. Proc. natn. Acad. Sci. 91, 3602–3606 (1994).
Qin, X.-Q., Livingston, D. M., Kaelin, W. G. & Adams, P. D. Proc. natn. Acad. Sci. U.S.A. 91, 10918–10922 (1994).
Shirodkar, S. et al. Cell 68, 157–166 (1992).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Xiao, ZX., Chen, J., Levine, A. et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375, 694–698 (1995). https://doi.org/10.1038/375694a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/375694a0
This article is cited by
-
Blockade of MDM2 with inactive Cas9 prevents epithelial to mesenchymal transition in retinal pigment epithelial cells
Laboratory Investigation (2019)
-
A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo
Oncogene (2018)
-
MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
Journal of Hematology & Oncology (2017)
-
A Functional Polymorphism (rs937283) in the MDM2 Promoter Region is Associated with Poor Prognosis of Retinoblastoma in Chinese Han Population
Scientific Reports (2016)
-
MDMX exerts its oncogenic activity via suppression of retinoblastoma protein
Oncogene (2015)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.